Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1371 of 6351
-
New eczema cream could be safer option for kids
Disease control Not yet recruitingThis randomized, open-label, parallel-group study will compare the efficacy and safety of Crisaborole 2% ointment and Tacrolimus 0.1% ointment in children with mild to moderate atopic dermatitis. A total of 66 participants will be randomized (1:1) to receive either Crisaborole or…
Phase 3 • Sponsor: Shalamar Institute of Health Sciences • Aim: Disease control
Last updated Jun 26, 2026 14:28 UTC
-
New hope for young minds: depression drug trial for children
Symptom relief Not yet recruitingDouble-Blind, Placebo-Controlled, Multicenter Study of Efficacy and Safety
Phase 4 • Sponsor: Bausch Health Americas, Inc. • Aim: Symptom relief
Last updated Jun 26, 2026 18:44 UTC
-
Can a smartphone app help former inmates kick stimulants and prevent HIV?
Disease control Recruiting nowJustice-involved individuals face disproportionately high rates of stimulant use disorder and HIV, along with disrupted access to HIV treatment and prevention services like ART and PrEP. Contingency management (CM) is the most effective intervention for stimulant use, but its use…
Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Gene secrets could explain why heart drug works for some, not others
Knowledge-focused Not yet recruitingThis research study, aims to understand why a specific heart medication called mavacamten works better for some people with hypertrophic cardiomyopathy (HCM) than for others. We believe the answer might be in our genes. The study focuses on two key areas: 1. The specific gene c…
Sponsor: University of Manchester • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
New combo therapy targets breast cancer brain metastases
Disease control Not yet recruitingA phase I clinical trial (a type of research study) for people with human epidermal growth factor receptor 2 (HER-2) positive breast cancer with metastasis to the brain. This research study will evaluate how well brain metastases can be controlled using a type of radiation therap…
Phase 1 • Sponsor: Baptist Health South Florida • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New hope for painful skin condition: drug trial launches
Disease control Not yet recruitingLichen planus (LP) is a common immune-mediated skin disease with a prevalence of 1-2% in the general population. It can present with a broad spectrum of clinical manifestations affecting primarily the skin (cutaneous LP \[CLP\]), the mucosae (mucosal LP \[MLP\]), hair follicles (…
Phase 2 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Liver cirrhosis bleeding: which procedure wins?
Disease control Not yet recruitingThis study aims to compare two treatments for cirrhotic portal hypertension with acute esophagogastric variceal bleeding and hypersplenism: laparoscopic splenectomy and azygoportal disconnection (LSD) and transjugular intrahepatic portosystemic shunt (TIPS). It is a single-center…
Sponsor: Northern Jiangsu People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New hope for ulcerative colitis patients who failed biologics?
Disease control Not yet recruitingThe primary objective of this trial is to evaluate the clinical efficacy of ATH-063 in participants with biologic/advanced therapy relapsed/refractory moderately to severely active UC.
Phase 2 • Sponsor: Athos Therapeutics Inc • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Could a daily cannabinoid pill tame tourette tics?
Symptom relief Not yet recruitingTo evaluate the efficacy, safety and tolerability of the cannabinoid-based medication SCI-110 compared to placebo in subjects with Tourette syndrome.
Phase 2 • Sponsor: Neurothera Labs Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New shot aims to toughen fragile bones in rare disease
Disease control Recruiting nowThis study is to evaluate the safety and efficacy of AGA2115 at three different dose regimens in Chinese adults and adolescents with Type I, III, or IV Osteogenesis imperfecta (OI).
Phase 2 • Sponsor: Angitia Biopharmaceuticals Guangzhou Limited • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Can simulated High-Altitude breathing boost lung cancer treatment?
Disease control Not yet recruitingThe goal of this clinical trial is to learn if adding intermittent hypoxic training (IHT) to standard neoadjuvant chemo-immunotherapy can increase the pathologic complete response (pCR) rate in patients aged 18 to 75 of both sexes with resectable stage II-IIIA lung squamous cell …
Phase 2 • Sponsor: zhang yi • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Can CBD or a nerve zap ease Athletes' Post-Concussion headaches?
Symptom relief Not yet recruitingDo cannabidiol (CBD) or vagus nerve stimulation reduce the frequency of persistent post-traumatic headache more than traditional oral headache medications?
Phase 2 • Sponsor: American Society of Pain and Neuroscience, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Blood thinner may stop organ failure in pancreatitis patients
Disease control Not yet recruitingThis clinical trial is designed to evaluate whether adding a standard blood-thinning medication, Unfractionated Heparin, to standard hospital care can help prevent severe organ failure in patients admitted with acute pancreatitis. Acute pancreatitis is a sudden and severe inflam…
Phase 4 • Sponsor: Allied Hospital Faisalabad • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Could a new eye drop beat an old favorite for glaucoma?
Disease control Not yet recruitingThis study aims to evaluate the safety and efficacy of DNN.31.19.026 compared with Cosopt® for the treatment of ocular hypertension or primary open-angle glaucoma.
Phase 3 • Sponsor: Ache Laboratorios Farmaceuticos S.A. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for myasthenia gravis patients: experimental drug enters phase 2 trial
Disease control Not yet recruitingThis study is a multicenter, randomized, double-blind, placebo-controlled Phase II clinical trial designed to evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of SHR-2173 compared to placebo as an add-on therapy to standard of care (SOC) for the treatment of …
Phase 2 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New Dual-Targeted PET scan aims to spot cancers more clearly
Diagnosis Not yet recruitingThis study aims to evaluate a novel dual-targeted PET imaging tracer, 68Ga-FAPI-PSMA, for the detection and evaluation of solid tumors. Fibroblast activation protein (FAP) and prostate-specific membrane antigen (PSMA) are two important molecular targets that are highly expressed …
Sponsor: Peking University Cancer Hospital & Institute • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
New combo aims to stop bleeding in bone marrow disease
Disease control Not yet recruitingThis study aims to compare the efficacy and safety of recombinant human thrombopoietin (rhTPO) + cyclosporine (CsA) and CsA monotherapy in the treatment of lower-risk myelodysplastic neoplasms with thrombocytopenia.
Phase 3 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New MRI-Guided brain zaps aim to ease anxiety in days
Symptom relief Not yet recruitingGeneralized Anxiety Disorder (GAD) is a common psychiatric disorder associated with persistent anxiety, functional impairment, and incomplete response to existing treatments. Although transcranial magnetic stimulation (TMS) has shown therapeutic potential in anxiety disorders, co…
Sponsor: Central South University • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Zapping stomach tumors with calcium: a new way to stop bleeding?
Disease control Not yet recruitingBrief Summary Background Gastric cancer (GC) remains a major global public health challenge, ranking as the fifth most common malignancy worldwide and the third leading cause of cancer-related mortality. In 2018, approximately 1 million new cases and 783,000 deaths were reported…
Sponsor: Hospital del Rio Hortega • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a smartwatch and remote coaching cut incontinence after prostate surgery?
Symptom relief Recruiting nowThe study titled " The effectiveness of telemedicine monitoring prehabilitation in prostate cancer patients undergoing radical prostatectomy " investigates the impact of a structured telemedicine-supported prehabilitation and rehabilitation program on reducing postoperative urina…
Sponsor: University Hospital Olomouc • Aim: Symptom relief
Last updated Jul 29, 2026 00:00 UTC